Host adaptive immunity deficiency in severe pandemic influenza

Critical Care

Volumn 14, Issue 5, 2010, Pages

  Bermejo Martin, Jesus F ^a   Martin Loeches, Ignacio ^b   Rello, Jordi ^c   Antón, Andres ^d   Almansa, Raquel ^a   Xu, Luoling ^e   Lopez Campos, Guillermo ^f   Pumarola, Tomás ^d   Ran, Longsi ^e   Ramirez, Paula ^g   Banner, David ^e   Cheuk Ng, Derek ^e   Socias, Lorenzo ^h   Loza, Ana ⁱ   Andaluz, David ^a   Maravi, Enrique ^j   Gómez Sánchez, Maria J ^j   Gordón, Mónica ^g   Gallegos, Maria C ^h   Fernandez, Victoria ^h   Aldunate, Sara ^j   León, Cristobal ⁱ   Merino, Pedro ^k   Blanco, Jesús ^k   Martin Sanchez, Fernando ^f   Rico, Lucia ^a   Varillas, David ^a   Iglesias, Veronica ^a   Marcos, Maria Ángeles ^d   Gandía, Francisco ^a   Bobillo, Felipe ^a   Nogueira, Begoña ^a   Rojo, Silvia ^a   Resino, Salvador ^l   Castro, Carmen ⁱ   Ortiz de Lejarazu, Raul ^a   Kelvin, David ^e,m,n   more..

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

^g HOSPITAL UNIVERSITARIO LA FE   (Spain)

^h HOSPITAL SON LLÀTZER   (Spain)

ⁱ HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^j Universidad Pública de Navarra   (Spain)

^k HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^l INSTITUTO DE SALUD CARLOS III   (Spain)

^m SHANTOU UNIVERSITY   (China)

ⁿ UNIVERSITY OF SASSARI   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CHEMOKINE; GRANZYME B; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10;

ADAPTIVE IMMUNITY; ADULT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; COMORBIDITY; CYTOKINE RELEASE; CYTOKINE STORM; DISEASE SEVERITY; FEMALE; GENE EXPRESSION PROFILING; HELPER CELL; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; INFLUENZA; INFLUENZA VIRUS A H1N1; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; MALE; NONHUMAN; OUTCOME ASSESSMENT; PANDEMIC; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRUS REPLICATION; COMPARATIVE STUDY; DOWN REGULATION; GENETICS; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED;

ADAPTIVE IMMUNITY; ADULT; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PANDEMICS; SEVERITY OF ILLNESS INDEX;

EID: 77956486528     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9259     Document Type: Article

References (31)

1. Pandemic influenza: the new wave. Lancet Infect Dis 2009, 9:583. 10.1016/S1473-3099(09)70236-1, 19778756.
2. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR, Hayden FG, Hui DS, Kettner JD, Kumar A, Lim M, Shindo N, Penn C, Nicholson KG. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010, 362:1708-1719. 10.1056/NEJMra1000449, 20445182.
3. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, Turgeon AF, Lapinsky S, Ahern SP, Smith O, Siddiqui F, Jouvet P, Khwaja K, McIntyre L, Menon K, Hutchison J, Hornstein D, Joffe A, Lauzier F, Singh J, Karachi T, Wiebe K, Olafson K, Ramsey C, Sharma S, Dodek P, Meade M, Hall R, Fowler RA, . Canadian Critical Care Trials Group H1N1 Collaborative Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009, 302:1872-1879. 10.1001/jama.2009.1496, 19822627, Canadian Critical Care Trials Group H1N1 Collaborative.
4. Webb SA, Pettila V, Seppelt I, Bellomo R, Bailey M, Cooper DJ, Cretikos M, Davies AR, Finfer S, Harrigan PW, Hart GK, Howe B, Iredell JR, McArthur C, Mitchell I, Morrison S, Nichol AD, Paterson DL, Peake S, Richards B, Stephens D, Turner A, Yung M. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009, 361:1925-1934. 10.1056/NEJMoa0908481, 19815860.
5. Rello J, Rodriguez A, Ibanez P, Socias L, Cebrian J, Marques A, Guerrero J, Ruiz-Santana S, Marquez E, Del Nogal-Saez F, Alvarez-Lerma F, Martinez S, Ferrer M, Avellanas M, Granada R, Maravi-Poma E, Albert P, Sierra R, Vidaur L, Ortiz P, Prieto del Portillo I, Galvan B, Leon-Gil C. Intensive care adult patients with severe respiratory failure caused by influenza A (H1N1)v in Spain. Crit Care 2009, 13:R148. 2784367, 19747383, 10.1186/cc8044.
6. Cameron MJ, Ran L, Xu L, Danesh A, Bermejo-Martin JF, Cameron CM, Muller MP, Gold WL, Richardson SE, Poutanen SM, Willey BM, DeVries ME, Fang Y, Seneviratne C, Bosinger SE, Persad D, Wilkinson P, Greller LD, Somogyi R, Humar A, Keshavjee S, Louie M, Loeb MB, Brunton J, McGeer AJ, Kelvin DJ. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol 2007, 81:8692-8706. 1951379, 17537853, 10.1128/JVI.00527-07.
7. De Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha do Q, Guan Y, Peiris JS, Chinh NT, Hien TT, Farrar J. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006, 12:1203-1207. 10.1038/nm1477, 16964257.
8. Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, Ramírez P, Martin-Loeches I, Varillas D, Gallegos MC, Serón C, Micheloud D, Gomez JM, Tenorio-Abreu A, Ramos MJ, Molina ML, Huidobro S, Sanchez E, Gordón M, Fernández V, Del Castillo A, Marcos MA, Villanueva B, López CJ, Rodríguez-Domínguez M, Galan JC, Cantón R, Lietor A, Rojo S, Eiros JM, Hinojosa C, Gonzalez I, Torner N, Banner D, Leon A, Cuesta P, Rowe T, Kelvin DJ. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care 2009, 13:R201. 2811892, 20003352, 10.1186/cc8208.
9. To KK, Hung IF, Li IW, Lee KL, Koo CK, Yan WW, Liu R, Ho KY, Chu KH, Watt CL, Luk WK, Lai KY, Chow FL, Mok T, Buckley T, Chan JF, Wong SS, Zheng B, Chen H, Lau CC, Tse H, Cheng VC, Chan KH, Yuen KY. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 2010, 50:850-859. 10.1086/650581, 20136415.
10. Giamarellos-Bourboulis EJ, Raftogiannis M, Antonopoulou A, Baziaka F, Koutoukas P, Savva A, Kanni T, Georgitsi M, Pistiki A, Tsaganos T, Pelekanos N, Athanassia S, Galani L, Giannitsioti E, Kavatha D, Kontopidou F, Mouktaroudi M, Poulakou G, Sakka V, Panagopoulos P, Papadopoulos A, Kanellakopoulou K, Giamarellou H. Effect of the novel influenza A (H1N1) virus in the human immune system. PLoS One 2009, 4:e8393. 2792719, 20037642, 10.1371/journal.pone.0008393.
11. Rowe T, Leon AJ, Crevar CJ, Carter DM, Xu L, Ran L, Fang Y, Cameron CM, Cameron MJ, Banner D, Ng DC, Ran R, Weirback HK, Wiley CA, Kelvin DJ, Ross TM. Modeling host responses in ferrets during A/California/07/2009 influenza infection. Virology 2010, 401:257-265. 10.1016/j.virol.2010.02.020, 20334888.
12. Cameron CM, Cameron MJ, Bermejo-Martin JF, Ran L, Xu L, Turner PV, Ran R, Danesh A, Fang Y, Chan PK, Mytle N, Sullivan TJ, Collins TL, Johnson MG, Medina JC, Rowe T, Kelvin DJ. Gene expression analysis of host innate immune responses during lethal H5N1 infection in ferrets. J Virol 2008, 82:11308-11317. 2573250, 18684821, 10.1128/JVI.00691-08.
13. Bosinger SE, Li Q, Gordon SN, Klatt NR, Duan L, Xu L, Francella N, Sidahmed A, Smith AJ, Cramer EM, Zeng M, Masopust D, Carlis JV, Ran L, Vanderford TH, Paiardini M, Isett RB, Baldwin DA, Else JG, Staprans SI, Silvestri G, Haase AT, Kelvin DJ. Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J Clin Invest 2009, 119:3556-3572. 2786806, 19959874.
14. Kendal APPM, Skehel JJ. Concepts and procedures for laboratory-based influenza surveillance. US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Atlanta, Georgia 1982,
15. Omnibus Gene Expression Database. , http://www.ncbi.nlm.nih.gov/geo
16. Lee HY, Topham DJ, Park SY, Hollenbaugh J, Treanor J, Mosmann TR, Jin X, Ward BM, Miao H, Holden-Wiltse J, Perelson AS, Zand M, Wu H. Simulation and prediction of the adaptive immune response to influenza A virus infection. J Virol 2009, 83:7151-7165. 2704765, 19439465, 10.1128/JVI.00098-09.
17. Hünig T, Lühder F, Elflein K, Gogishvili T, Fröhlich M, Guler R, Cutler A, Brombacher F. CD28 and IL-4: two heavyweights controlling the balance between immunity and inflammation. Med Microbiol Immunol 2010, 199(3):239-246. 10.1007/s00430-010-0156-z, 20390297.
18. Janssen EM, Lemmens EE, Gour N, Reboulet RA, Green DR, Schoenberger SP, Pinkoski MJ. Distinct roles of cytolytic effector molecules for antigen-restricted killing by CTL in vivo. Immunol Cell Biol 2010,
19. McLean JE, Ruck A, Shirazian A, Pooyaei-Mehr F, Zakeri ZF. Viral manipulation of cell death. Curr Pharm Des 2008, 14:198-220. 10.2174/138161208783413329, 18220831.
20. Bhoj VG, Chen ZJ. Ubiquitylation in innate and adaptive immunity. Nature 2009, 458:430-437. 10.1038/nature07959, 19325622.
21. Schneider C, Van Regenmortel MH. Immunogenicity of free synthetic peptides corresponding to T helper epitopes of the influenza HA 1 subunit. Induction of virus cross reacting CD4+ T lymphocytes in mice. Arch Virol 1992, 125:103-119. 10.1007/BF01309631, 1379424.
22. Flynn KJ, Belz GT, Altman JD, Ahmed R, Woodland DL, Doherty PC. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 1998, 8:683-691. 10.1016/S1074-7613(00)80573-7, 9655482.
23. Plotnicky H, Cyblat-Chanal D, Aubry JP, Derouet F, Klinguer-Hamour C, Beck A, Bonnefoy JY, Corvaia N. The immunodominant influenza matrix T cell epitope recognized in human induces influenza protection in HLA-A2/K(b) transgenic mice. Virology 2003, 309:320-329. 10.1016/S0042-6822(03)00072-2, 12758178.
24. Bermejo-Martin JF, Garcia-Arevalo MC, Alonso A, De Lejarazu RO, Pino M, Resino S, Tenorio A, Bernardo D, Leon AJ, Garrote JA, Ardura J, Dominguez-Gil M, Eiros JM, Blanco-Quiros A, Munoz-Fernandez MA, Kelvin DJ, Arranz E. Persistence of proinflammatory response after severe respiratory syncytial virus disease in children. J Allergy Clin Immunol 2007, 119:1547-1550. 10.1016/j.jaci.2007.03.014, 17451801.
25. Poehlmann H, Schefold JC, Zuckermann-Becker H, Volk HD, Meisel C. Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis. Crit Care 2009, 13:R119. 2750167, 19604380, 10.1186/cc7969.
26. Venteclef N, Delerive P. Interleukin-1 receptor antagonist induction as an additional mechanism for liver receptor homolog-1 to negatively regulate the hepatic acute phase response. J Biol Chem 2007, 282:4393-4399. 10.1074/jbc.M608993200, 17158876.
27. McKinstry KK, Strutt TM, Buck A, Curtis JD, Dibble JP, Huston G, Tighe M, Hamada H, Sell S, Dutton RW, Swain SL. IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J Immunol 2009, 182:7353-7363. 2724021, 19494257, 10.4049/jimmunol.0900657.
28. Jones HP, Tabor L, Sun X, Woolard MD, Simecka JW. Depletion of CD8+ T cells exacerbates CD4+ Th cell-associated inflammatory lesions during murine mycoplasma respiratory disease. J Immunol 2002, 168:3493-3501.
29. Gonzalez PA, Bueno SM, Riedel CA, Kalergis AM. Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis. Curr Med Chem 2009, 16:4609-4625. 10.2174/092986709789760724, 19903147.
30. Muenzer JT, Davis CG, Chang K, Schmidt RE, Dunne WM, Coopersmith CM, Hotchkiss RS. Characterization and modulation of the immunosuppressive phase of sepsis. Infect Immun 2010, 78:1582-1592. 10.1128/IAI.01213-09, 20100863.
31. WHO guidelines for pharmacologic management of pandemic (H1N1) 2009 influenza and other influenza viruses. (Accessed 03/07/2010)., http://www.who.int/csr/resources/publications/swineflu/h1n1_use_antivirals_20090820/en/index.html